2024-05-06 17:21:48 ET
More on Vertex Pharmaceuticals
- Vertex Pharmaceuticals: Alpine Accelerates Aspiration To Become Biotech Powerhouse
- Alpine: Vertex Acquisition Brings About More Than IgA Nephropathy Advancement
- What Vertex Pharmaceuticals Is Getting With Acquisition Of Alpine Immune Sciences
- Vertex Pharmaceuticals Non-GAAP EPS of $4.76 beats by $0.70, revenue of $2.69B beats by $110M
- J&J, Roche, AstraZeneca poised to have highest orphan drug sales by end of decade
Read the full article on Seeking Alpha
For further details see:
Vertex provides another EPS beat as net income rises 56% in Q1